Found 21 matching trials
A Study in Healthy People to Test if Taking Different Formulations of BI 425809 Tablets Influences the Amount of BI 425809 in the Blood PHASE1 The main objective of this trial is to investigate the relative bioavailabi...
Show More Location
Humanpharmakologisches Zentrum Biberach
Learn More & Join Trial
Study of TF2 Carcinoembryonic Antigen (CEA) Antibody in Patients With Metastatic Colorectal Cancer PHASE1 This study is being done to select an appropriate TF2 bsMAb dose suitable f...
Show More Location
Georgetown University Medical Center
Learn More & Join Trial
A Study in Healthy People to Compare Two Different Tablets of BI 685509 and to Test How Food and Esomeprazole Influence the Amount of BI 685509 in the Blood PHASE1 The main objective of this trial is to investigate:
* the relative bioavai...
Show More Location
Humanpharmakologisches Zentrum Biberach
Learn More & Join Trial
TF2- Small Cell Lung Cancer Radio Immunotherapy PHASE1 Lung cancer is currently the leading cause of cancer death in both men and ...
Show More Learn More & Join Trial
Relative Bioavailability (rBA) of Evobrutinib Intended Commercial and Clinical Tablets, and Effect of Food on Intended Commercial Tablets PHASE1 The study will evaluate the relative bioavailability (rBA) of the intended ...
Show More Learn More & Join Trial
Clinical Study on Auricular Points Sticking Plus Chinese Medication for Hot Flashes in Breast Cancer Women NA Object:The aim of this study was to investigate the effectiveness of sticki...
Show More Learn More & Join Trial
A Study to Evaluate the Relative Bioavailability and Food Effect of a New Tablet Formulation of VX-548 PHASE1 The purpose of this study is to evaluate the relative bioavailability and f...
Show More Location
ICON Salt Lake City
Learn More & Join Trial
Acupoint Stimulation for Pain Reduction and the Associated Benefits in Head and Neck Cancer Patients Receiving Concurrent Chemoradiotherapy NA This study was designed to investigate the effect of Acupoint stimulation o...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Pretargeted Radioimmunotherapy of a Anti-CEA Bispecific Antibody and Lu177-labeled Peptide in Colorectal Cancer PHASE1 This study will investigate the toxicity, safety and pharmacokinetics of pr...
Show More Location
Radboud University Nijmegen Medical Centre
Learn More & Join Trial
Bispecific Antibody in Finding Tumor Cells in Patients With Colorectal Cancer PHASE1 RATIONALE: Diagnostic procedures, such as radionuclide imaging using bispec...
Show More Location
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
Learn More & Join Trial